TrialBlood2020

Outcomes of older patients in ZUMA-1, a pivotal study of axicabtagene ciloleucel in refractory large B-cell lymphoma.

Sattva S Neelapu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.